ID   TUHR3TKB
AC   CVCL_5956
SY   TUHR-3TKB
DR   CLO; CLO_0050895
DR   BioSample; SAMN03472175
DR   RCB; RCB1187
DR   Wikidata; Q54973373
RX   PubMed=9914789;
CC   Population: Japanese.
CC   HLA typing: A*02,24:02 (PubMed=9914789).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): RCB=RCB1187
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,10
ST   D16S539: 10,12
ST   D5S818: 10,11
ST   D7S820: 9,10
ST   TH01: 6,9
ST   TPOX: 9,11
ST   vWA: 18,19
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
RX   PubMed=9914789; DOI=10.1111/j.1349-7006.1998.tb00515.x; PMCID=PMC5921718;
RA   Liu, Shu-Qin
RA   Kawai, Koji
RA   Shiraiwa, Hiroshi
RA   Hayashi, Hitoshi
RA   Akaza, Hideyuki
RA   Hashizaki, Kazuko
RA   Shiba, Reiko
RA   Saijo, Kaoru
RA   Ohno, Tadao
RT   "High rate of induction of human autologous cytotoxic T lymphocytes
RT   against renal carcinoma cells cultured with an interleukin
RT   cocktail.";
RL   Jpn. J. Cancer Res. 89:1195-1201(1998).
//